• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Guo Yanru

    4/24/26 10:44:35 AM ET
    $ZJYL
    Industrial Specialties
    Health Care
    Get the next $ZJYL alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Guo Yanru

    (Last)(First)(Middle)
    C/O JIN MEDICAL INTERNATIONAL LTD.
    NO. 33 LINGXIANG ROAD, WUJIN DISTRICT

    (Street)
    CHANGZHOUJIANGSU

    (City)(State)(Zip)

    CHINA

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    Jin Medical International Ltd. [ ZJYL ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    XDirector10% Owner
    Officer (give title below)Other (specify below)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Yanru Guo04/24/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $ZJYL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZJYL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZJYL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Guo Yanru

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:44:35 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    New insider Wang Erqi claimed ownership of 4,306,307 units of Class A Ordinary Shares and claimed ownership of 1,000,000 units of Class B Ordinary Shares (SEC Form 3)

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:43:55 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 3 filed by new insider Wang Ziqiang

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:42:49 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

    CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement. The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.T

    4/7/26 7:00:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative

    CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination of all its authorized and issued ordinary shares (the "Stock Combination") pursuant to the authorization granted from an extraordinary general meeting of the Company's shareholders on January 30, 2026 (the "EGM"). Effective as of the date of the EGM, the Company's authorized share capital is reclassified into a dual class of Class A ordinary shares

    3/11/26 7:30:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    Jin Medical CEO Fireside Chat

    CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat on February 2, 2026 where the CEO shared some insights into the Company's recent strategic priorities and long-term growth considerations. The following questions were prepared by the Company and addressed by the Company's CEO, Dr. Erqi Wang during the conversation. Certain statements made during the discussion were forward-looking, and the Company provided a cautionary note regarding forward-looking statements prior to the start of th

    2/5/26 8:57:00 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    SEC Filings

    View All

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    4/7/26 4:30:01 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by JIN MEDICAL INTERNATIONAL LTD.

    6-K - Jin Medical International Ltd. (0001837821) (Filer)

    3/17/26 4:30:16 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 20-F filed by JIN MEDICAL INTERNATIONAL LTD.

    20-F - Jin Medical International Ltd. (0001837821) (Filer)

    2/9/26 8:55:46 PM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $ZJYL
    Financials

    Live finance-specific insights

    View All

    Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023

    CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ:ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 ("the period"). Financial and Operational Highlights for Six Months Ended March 31, 2023 Revenues were $10.25 million, representing an 8.3% increase from $9.47 million for the first six months ended March 31, 2022.Revenues from wheelchair products were $8.38 million, an increase of 5.4% from $7.95 million for the six months ended March 31, 2022.Revenues from whee

    8/23/23 4:15:00 PM ET
    $ZJYL
    Industrial Specialties
    Health Care